MEDIA

Latest News

Revance is a biotechnology company focused on innovative aesthetic and therapeutic offerings, as well as financial technology services for aesthetic practices.

Main Menu
Dermatology Times logo

FDA Accepts BLA Resubmission for DAXI Injections

LEARN MORE
Street Insider Logo

Revance Therapeutics (RVNC) Announces FDA Acceptance of BLA Resubmission for DaxibotulinumtoxinA for Injection for Glabellar Lines)

LEARN MORE
Bezinga Logo

Revance Receives FDA Acceptance of BLA Resubmission for DaxiboutlinumtoxinA for Glabellar Lines

LEARN MORE
Seeking Alpha logo

FDA Accepts Revance Application for Its Injection To Treat Frown Lines

LEARN MORE